One Small Molecule, Potential Giant Step to Improve Cognitive Function
One Small Molecule, Potential Giant Step to Improve Cognitive Function
A $6.1 million study led by the UArizona Center for Innovation in Brain Science will test novel small molecules to improve the lives of Alzheimer ' s patients.
Center for Innovation in Brain Science
Tuesdaydependent-100343_1280-web.jpg
The study could lead to the submission of an investigational new drug for the treatment of Alzheimer's and related dementias.HealthScience and TechnologyCollege of Medicine - TucsonResearcher contact:
Kathleen Rodgers
Center for Innovation in Brain Science
562-234-6532krodgers@arizona.eduMedia contact:
Gloria Bloomer
Center for Innovation in Brain Science
Office: 520-626-4164 | Mobile: 520-906-7998gbloomer@arizona.eduWith only five available drugs approved by the U.S. Food and Drug Administration to treat Alzheimer ' s disease – and no drugs to prevent or cure it – the National Institute on Aging has awarded a $6.1 million grant to the Center for Innovation in Brain Science at the University of Arizona Health Sciences to investigate a novel approach to treat the disease.The study will seek to advance the development of a small molecule Mas agonist leading to the submission of an investigational new drug for the treatment of Alzheimer ' s and related dementias. Mas agonists are used to bind to and activate biological receptors, and this study will involve the renin-angiotensin system, a hormone system that regulates blood pressure, fluid balance and vascular ...
Source: The University of Arizona: Health - Category: Universities & Medical Training Authors: mittank Source Type: research
More News: Alzheimer's | Brain | Cardiology | Cardiovascular | Clinical Trials | Dementia | Drugs & Pharmacology | Food and Drug Administration (FDA) | Genetics | Grants | Heart | Hormones | Investigational New Drugs | National Institutes of Health (NIH) | Neurology | Neuroscience | Science | Study | Universities & Medical Training | Websites